Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2018-06-07 Regulatory Filings
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Phosphagenics Still Awaits SIAC Arbitration Update 2 pages 226.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Phosphagenics Limited regarding the status of an arbitration update from the Singapore International Arbitration Centre (SIAC). It is dated 8 June 2018 and contains no financial statements, no detailed financial data, no management discussion of financial results, nor any regulatory filing references. The content is an update on a legal/arbitration matter, not a financial report or earnings release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a report publication announcement or certification. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into any other specific category.
2018-06-07 English
Final Director's Interest Notice 2 pages 211.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including options held, and notes the date the director ceased to be a director. This is a report of personal share transactions or holdings by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial results or other report content. Therefore, the appropriate classification is Director's Dealing (DIRS).
2018-05-30 English
AGM Chairman's Address and CEO Presentation 17 pages 730.5KB
AGM Information Classification · 100% confidence The document is a detailed communication from Phosphagenics Limited related to their Annual General Meeting (AGM) held on 25 May 2018. It includes the Chairman's address and the CEO's presentation, both of which are typical components of AGM materials. The text explicitly mentions the AGM, the Chairman's address, and the CEO's presentation to the Annual General Meeting. The content focuses on company strategy, operational highlights, partnerships, and future outlook, which are typical for AGM presentations. There is no indication that this is a full annual report (10-K), earnings release, or other regulatory filing. The document is not a brief announcement or a report publication notice but rather the actual presentation and speech content delivered at the AGM. Therefore, the appropriate classification is AGM Information (AGM-R).
2018-05-24 English
2018 Annual General Meeting Results 2 pages 355.6KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '2018 Annual General Meeting Results' and provides detailed voting results for resolutions passed at the AGM held on 25 May 2018. It references compliance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, which relate to disclosure of voting outcomes. The content includes proxy votes, votes for and against, and whether resolutions were carried or not. The document is relatively short (3665 characters) and focuses solely on the voting results of the AGM, not the full AGM materials or presentations. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2018-05-24 English
Retirement of Non-Executive Director 1 page 217.6KB
Board/Management Information Classification · 100% confidence The document is a short announcement from Phosphagenics Limited regarding the retirement of a Non-Executive Director, Mr. Peter Lankau, who chose not to stand for re-election at the Annual General Meeting. It contains no financial data, no detailed report, and no mention of any financial results or filings. The content is focused on a change in the company's board of directors. The document length is only 1912 characters, indicating it is a brief announcement rather than a full report. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-05-24 English
Phospahgenics CEO Roadshow Presentation 24 pages 1.7MB
Investor Presentation Classification · 95% confidence The document is titled 'Updated Non-Confidential Investor Presentation for CEO Roadshow' and contains detailed information about the company's technology, product pipeline, market opportunities, partnerships, and strategic outlook. It includes forward-looking statements, risk disclosures, and a comprehensive overview of the business and financial positioning. The content is structured as a presentation aimed at investors, with slides and bullet points describing the company's mission, products, market potential, and arbitration updates. There are no financial statements or quarterly results, nor is it an announcement of a report publication or regulatory filing. The document is clearly an investor presentation intended to inform and attract investors about the company's prospects and strategy.
2018-05-13 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.